News
Find related articles on
Latest News
Recent comments
- Debbie on Current DTC genetic testing market smaller than expected (30/08/2010)
- Fred on FDA moves to halt unproven stem cell treatments (25/08/2010)
- Mary on FDA grapples with regulation of DTC genetic tests (27/07/2010)
- David on Support for adult stem cell research (27/04/2010)
- David Bonthron on Genetic effects of marriage between cousins exaggerated (31/03/2010)
New open access chemogenomic database
The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) recently launched a new online database of genomic-based drug and small molecule information. This open access database, ChEMBLdb, is intended as a resource for researchers aiming to develop potential new therapeutics based on genomic data. It includes records of more than half a million small molecule compounds and their effects on biological systems. ChEMBL team leader Dr John Overington commented: "We hope ChEMBLdb will assist the translation of genomic-based insights into innovative drug therapies" (see press release)
Unusually, this resource was originally a commercial database but was purchased with a £4.7 million Strategic Award from the Wellcome Trust; their director of science funding Alan Schafer said that the move “should have the greatest impact on researchers in academia and in small companies on limited budgets”.